Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA’s Cavazzoni Says Retaining Virtual Meetings Could Improve Communications Going Forward

Executive Summary

One of the lessons learned from the pandemic may be that virtual meetings can be used in place of an in-person session more often.

You may also be interested in...



Pondering The Future Of In-Person Meetings At The US FDA

Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.

US FDA Drug Center Director Cavazzoni’s Top Priority: Winning ‘Hearts And Minds’

Patrizia Cavazzoni, FDA Center for Drug Evaluation and Research director, knows she has ‘huge shoes’ to fill. Convincing the CDER staff that she is capable of doing so is job one.

US FDA Drug Center Director’s Top Priority: Winning ‘Hearts And Minds’

Patrizia Cavazzoni, the new director of the US FDA Center for Drug Evaluation & Research, knows that the has ‘huge shoes’ to fill. Convincing the CDER staff that she is capable of doing so is job one.

Related Content

Topics

UsernamePublicRestriction

Register

PS144371

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel